About

The modern individual, in their quest for optimal health or the best possible treatment in case of illness, is inevitably subjected to numerous medical examinations and diagnoses, making the so-called "patient journey" highly complex. While all the information necessary for ideal health is stored within a single cell, modern medical science is still unable to leverage this data on a large scale to provide truly personalized healthcare services and treatments. Moreover, there is no comprehensive health management solution that offers diagnosis at the cellular level, along with personalized prognosis and treatment. The application of therapies that achieve so-called reverse biology is not feasible in most cases, and where it is possible, it comes at an extremely high cost, often requiring invasive procedures rather than enabling natural self-healing. IMON MED is a medical company operating in the field of personalized medicine and comprehensive health management, aiming to provide high-end services

Solution & Product

Having patented its entire methodology, IMON MED offers its approach to doctors and healthcare professionals, enabling them to provide high-quality healthcare services and specifically: a)Special Metabolic Flexibility Bio-KIT Assessment & Interpretation IMON MED can diagnose precisely the metabolic flexibility on cellular base using special Laboratory Collection KITS, based on multi-omics techniques b) Diagnostic and Prognostic Algorithms Using cutting-edge sciences such as epigenetics, metabolomics, proteomics, lipidomics, and other “omics” disciplines, can interpret and correlate - with biochemical and Hormonal Profile - ones Health status. Capable of detecting cell-level abnormalities, damage, dysfunctions, and predispositions. can provide diagnosis and prognosis using IMON Algorithms c) Reverse Biology natural treatments Activation of metabolic pathways can provide targeted nutritional therapies. d) Patented Methodology Can provide training and licensing to healthcare professionals, physicians and experts e) End-to end solution with wed platform and app both for experts and users

Innovation & Scalability

IMON MED attains the first medical patent on cellular reprogramming and self- treatment. Its scalability steps incluse: - Expansion and adoption of the methodology by healthcare professionals worldwide. - Further enhancement of self-healing applications, reducing reliance on invasive or prohibitively expensive therapies. - Creation of a new era in personalized medicine, where high-quality healthcare services are accessible to everyone. - Potential for widespread application of “reverse biology” at an affordable cost.

Traction & achievements

- The first holistic approach that combines diagnosis, prognosis, and treatment on a cell- level. - Development of globally innovative algorithms integrating multiple “omics” sciences. - Successful patent protection for the entire methodology.

Team & Why Us

IMON MED is led by a team of highly experienced professionals with deep expertise in metabolic health, precision medicine, biotechnology, and business strategy. I-M-Ó-N Med positions itself as the world’s most innovative biotechnology-driven holistic health and wellness solution, bridging the gap between medical science and everyday well-being. Its unique patented remote assessment technology allows for the detection, management, and optimization of human metabolic function, providing truly personalized health management through advanced metabolic algorithms and digital health services. Unique Value Proposition Focus on preventive and self-healing therapies rather than invasive care. Global Expansion Strategy (2025–2030) Phase 1: Scale (Year 1) Target: Early adopters in Europe & Middle East. Partnerships with medical clinics, nutrition centers, and wellness chains. Launch remote diagnostic kits + digital platform (app/portal). Phase 2: Growth (Year 2–3) Expand to North America & Asia-Pacific with strategic distribution. Collaborations with insurance providers and corporate wellness programs. Develop B2B2C model (clinics/doctors offering IMON Med services). Phase 3: Global Scale (Year 4–5) Full global rollout in 25+ countries. Integration with AI-driven predictive health analytics. Expansion into consumer high-end interactive technologies (like facescanning) & continuous monitoring devices.

Funding Needs

5 m;illion for a 5year plan Year 1 – Awareness & Trust (Budget €750k) Branding & storytelling campaign: “Health starts at the cell.” Key actions: Website, app, and content ecosystem. Partnerships with key opinion leaders (KOLs) in biotech & wellness. Scientific publications + participation in global medical conferences. Year 2 – Market Entry & Education (Budget €1M) Target markets: Switzer;and, UK, UAE, Greece, USA. Key actions: Digital campaigns on LinkedIn, Meta, and medical journals. Launch remote test kits and subscription health plans. Educational webinars for doctors and healthcare professionals. Year 3 – Acceleration & Partnerships (Budget €1.25M) Scale to corporate wellness programs (Fortune 500, insurance firms). Key actions: Co-branding campaigns with clinics & hospitals. Sponsorship of global wellness summits. Develop premium membership platform (telehealth + nutrition). Year 4 – Consumer Expansion (Budget €1M) Move into B2C mass-market wellness & preventive care. Key actions: Influencer partnerships & lifestyle campaigns. Integration with wearable devices (Apple Health, Fitbit, Garmin). Multilingual expansion: Southouth & Central EU, Chinese, Arabic. Year 5 – Global Leadership (Budget €1M) Establish I-M-Ó-N Med as a global brand in personalized longevity care. Key actions: Launch global health & longevity index. Expand to 25+ countries, targeting 5M+ users. Strategic alliances with WHO initiatives and global health NGOs.